Effects of maternal age and education on the pattern of prenatal testing: Implications for the use of antenatal screening as a solution to the growing number of amniocenteses

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 5, 2003, Pages 1336-1342

  Khoshnood, Babak ^a   Blondel, Béatrice ^a   De Vigan, Catherine ^a   Bréart, Gérard ^a  

^a INSERM   (France)

Author keywords

Amniocentesis; Down syndrome; Maternal serum screening; Prenatal diagnosis

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CONTROLLED STUDY; EDUCATION; FEMALE; FRANCE; HUMAN; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING;

EID: 0346751040     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00643-4     Document Type: Article

References (25)

1. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
2. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997;337:1654-8.
3. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994;330:1114-8.
4. Egan JF, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000;96:979-85.
5. Casterline JB, Lee RD, Foote KA. Fertility in the United States: new patterns, new theories. New York: Population Council; 1996.
6. Bréart G. Delayed childbearing. Eur J Obstet Gynecol Reprod Biol 1997;75:71-3.
7. Khoshnood B. Impact of advanced maternal age on the risk for adverse birth outcomes in the United States [dissertation]. Chicago: University of Chicago; 2001.
8. Kolker A. Advances in prenatal diagnosis: social-psychological and policy issues. Int J Technol Assess Health Care 1989;5:601-17.
9. Moatti JP, Le Gales C, Julian C, Durbec JP, Mattei JF, Ayme S. Sociocultural inequities in access to prenatal diagnosis: the role of insurance coverage and regulatory policies. Prenat Diagn 1990;10: 313-25.
10. Halliday J, Lumley J, Watson L. Comparison of women who do and do not have amniocentesis or chorionic villus sampling. Lancet 1995;345:704-9.
11. Khoshnood B, Pryde P, Wall S, Singh J, Mittendorf R, Lee KS. Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome. Am J Public Health 2000;90:1778-81.
12. Chilaka VN, Konje JC, Stewart CR, Narayan H, Taylor DJ. Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 2001;21:159-64.
13. Ayme S, Morichon N, Goujard J, Nisand I. Prenatal diagnosis in France. Eur J Hum Genet 1997;5(1 Suppl):26-31.
14. De Vigan C, Vodovar V, Verite V, Dehe S, Goujard J. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97. Prenat Diagn 1999;19:1113-8.
15. Blondel B, Norton J, du Mazaubrun C, Bréart G, pour la coordination nationale des enquêtes nationales périnatales. Trends in main indicators of perinatal health in France between 1995 and 1998: results from the National Perinatal Surveys. J Gynecol Obstet Biol Reprod (Paris) 2001;30:552-64.
16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-48.
17. Hosmer D Jr, Lemeshow S, Applied logistic regression. New York: John Wiley; 1989.
18. Khoshnood B, Blondel B, De Vigan C, Bréart G. Socioeconomic barriers to making informed decisions about maternal serum screening for Down syndrome: results of the National Perinatal Survey of 1998 in France. Am J Public Health. In press
19. Seror V, Costet N, Down syndrome serum marker screening: decision criteria and implicit values. Health Policy 1998;43:83-96.
20. Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol 2000;96:511-6.
21. Kuppermann M, Feeny D, Gates E, Posner SF, Blumberg B, Washington AE. Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most. Prenat Diagn 1999;19:711-6.
22. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995;15:1215-26.
23. Pryde PG, Drugan A, Johnson MP, Isada NB, Evans MI. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results. Clin Obstet Gynecol 1993;36:469-509.
24. Smith DK, Shaw RW, Marteau TM. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ 1994;309:776.
25. Asch A. Prenatal diagnosis and selective abortion: a challenge to practice and policy. Am J Public Health 1999;89:1649-57.